Affiliation:
1. Department of Chemistry, Hindu College, Amritsar-143005, India
2. Department of Chemistry, Baring Union Christian College, Batala-143505, India
Abstract
Cancer is among the most severe risks to the global human population. The enduring crisis of drug-resistant cancer and the limited selectivity of anticancer drugs are significant roadblocks to its control and eradication, requiring the identification of new anticancer entities. The stable aromatic nature, reversible redox properties, and low toxicity of ferrocene revolutionized medicinal organometallic chemistry, providing us with bioferrocene compounds with excellent antiproliferative potential, which has been the focus of persistent efforts in recent years. Substituting the aryl/heteroaryl core for ferrocene in an organic molecule alters its molecular characteristics, including solubility, hydro-/lipophilicity, as well as bioactivities. Ferrocifen (ferrocene analogues of hydroxytamoxifen) has shown antiproliferative potential in both hormone-dependent (MCF-7) and hormone-independent (MDA-MB-231) breast cancer cells. It is now in pre-clinical trials against malignancies. These entities operate through various targets, some of which have been revealed and activated in response to product concentrations. They also react to the cancer cells by diverse mechanisms that can work in concert or in isolation, depending on signaling pathways that promote senescence or death. The behavior of ferrocene-containing hybrids with a range of anticancer targets is explained in this chapter.
Publisher
BENTHAM SCIENCE PUBLISHERS
Reference194 articles.
1. Shafiq N.; Arshad U.; Zarren G.; Parveen S.; Javed I.; Ashraf A.; A comprehensive review: Bio-potential of barbituric acid and its analogues. Curr Org Chem 2020,24(2),129-161
2. Guillén Sans R.; Guzmán Chozas M.; Historical aspects and applications of barbituric acid derivatives. A review. Pharmazie 1988,43(12),827-829
3. Shaker R.M.; Ishak E.A.; Barbituric acid utility in multi-component reactions. Z Naturforsch B J Chem Sci 2011,66(12),1189-1201
4. Moussier N.; Bruche L.; viani F.; Zanda M.; Fluorinated barbituric acid derivatives: synthesis and bio-activity. Curr Org Chem 2003,7(11),1071-1080
5. Mulinos M.G; Iso-amyl-ethyl-barbituric acid (amytal) as a laboratory anesthetic for cats. J Pharmacol Exp Ther 1928,34(4),425-435